WO2025242182 - COMPOUNDS, CONJUGATES, AND PHARMACEUTICAL COMPOSITIONS
National phase entry is expected:
Publication Number
WO/2025/242182
Publication Date
27.11.2025
International Application No.
PCT/CN2025/096675
International Filing Date
22.05.2025
Title **
[English]
COMPOUNDS, CONJUGATES, AND PHARMACEUTICAL COMPOSITIONS
[French]
COMPOSÉS, CONJUGUÉS ET COMPOSITIONS PHARMACEUTIQUES
Applicants **
HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD
HANGZHOU DAC BIOTECHNOLOGY CO., LTD
ZHAO, Robert Yongxin
Inventors
YANG, Qingliang
HUANG, Yuanyuan
YE, Hangbo
ZHANG, Lingli
GUO, Huihui
JIA, Junxiang
WANG, Juan
LI, Wenjun
BAI, Lu
HU, Jialei
XIE, Xiaoqiang
LIU, Xiaolei
WANG, Junpeng
LUO, Yi
XU, Yifang
ZHAO, Gengxiang
YANG, Nanyan
Priority Data
PCT/CN2024/094651
22.05.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3688 | |
| EPO | Filing, Examination, Granting | 23806 | |
| Japan | Filing, Examination, Granting | 2525 | |
| South Korea | Filing, Examination, Granting | 2821 | |
| USA | Filing, Examination, Granting | 9540 |
Total:
42,380
Contact Us
Abstract[English]
It relates to a compound and its conjugate for enhancing the targeted treatment of prostate cancers and other tumors. Pharmaceutical compositions and methods for treating cancers are provided.[French]
L'invention concerne un composé et son conjugué pour améliorer le traitement ciblé de cancers de la prostate et d'autres tumeurs. L'invention concerne des compositions pharmaceutiques et des méthodes de traitement de cancers.